Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Masonic Cancer Center, University of Minnesota
Sponsor:
Information provided by (Responsible Party):
Masonic Cancer Center, University of Minnesota
ClinicalTrials.gov Identifier:
NCT00303719
First received: March 15, 2006
Last updated: August 15, 2016
Last verified: August 2016